You are viewing: Rest Of Asia Pacific ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Rest Of Asia Pacific ECMO Machines Market was valued at $13.1 Million in 2025 and projected to reach to $18 Million by 2030, representing a compound annual growth rate of 6.5%. Rest Of Asia Pacific's ECMO machines market is positioned for sustained growth through 2030, driven by expanding healthcare infrastructure investments and rising adoption of advanced critical care technologies.

Rest Of Asia Pacific ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific ECMO Machines Market Trends and Insights

  • Middle East & Africa's growth trajectory reflects increasing adoption of extracorporeal membrane oxygenation technology in critical care settings, driven by rising healthcare infrastructure investments and growing prevalence of cardiac and respiratory conditions.
  • The region's 6.5% compound annual growth rate outpaces the global average, indicating accelerating demand for advanced life support solutions across Middle East & Africa's healthcare systems. Middle East & Africa's ECMO market is characterized by expanding hospital capacity and enhanced access to critical care technologies in both developed and emerging economies within the region.
  • Middle East & Africa's healthcare providers are increasingly recognizing ECMO's clinical value in managing severe cardiopulmonary failure, particularly in tertiary care centers.
  • Between 2025 and 2030, Middle East & Africa is expected to see significant capital investments in medical device infrastructure, supporting the deployment of ECMO systems across major healthcare facilities..

Key Market Statistics

  • CAGR (2025-2030) 6.5% CAGR
  • Market Size, 2025 ~USD 13.1 Million
  • Forecast, 2030 ~USD 18 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific ECMO Machines Market Overview

Market Valuation :

Rest Of Asia Pacific ECMO machines market valued at USD 13.1 million in 2025, demonstrating significant growth potential in emerging healthcare economies across the region.

Strong Growth Trajectory :

Market projected to reach USD 18.0 million by 2030, with a robust CAGR of 6.5%, outpacing the global average of 5.8% and indicating accelerating adoption rates.

Healthcare Infrastructure Expansion :

Rising investments in critical care infrastructure across Rest Of Asia Pacific countries are driving ECMO technology adoption in tertiary care centers and specialized cardiac facilities.

Clinical Demand Growth :

Increasing prevalence of cardiac and respiratory complications, coupled with growing awareness of extracorporeal membrane oxygenation benefits, fuels market expansion in the region.

Rest Of Asia Pacific ECMO Machines Market Dynamics

  • The region's emerging economies are increasingly prioritizing cardiac and respiratory care capabilities, creating favorable conditions for ECMO system deployment.
  • Healthcare providers are recognizing the clinical value of extracorporeal membrane oxygenation in managing complex patient cases, particularly in specialized cardiac centers and tertiary care institutions. The market's 6.5% CAGR reflects growing healthcare expenditure, improving reimbursement frameworks, and enhanced clinical training programs across Rest Of Asia Pacific nations.
  • Strategic partnerships between international ECMO manufacturers and regional healthcare providers are facilitating technology transfer and market penetration.
  • As healthcare systems mature and critical care demand intensifies, ECMO adoption is expected to accelerate, positioning Rest Of Asia Pacific as a high-growth market segment within the broader Asia Pacific region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Middle East & Africa ECMO machines market valued at USD 13.1 million in 2025, expanding to USD 18.0 million by 2030
    • Middle East & Africa demonstrates 6.5% CAGR, outpacing global growth rate and reflecting strong regional demand
    • Middle East & Africa's healthcare infrastructure investments are driving adoption of advanced critical care technologies
    • Middle East & Africa's tertiary care centers are increasingly deploying ECMO systems for severe cardiopulmonary conditions

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Rest Of Asia Pacific ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • ECMO Device Manufacturers : Require detailed Rest Of Asia Pacific market data to identify expansion opportunities, assess market entry feasibility, and develop localized commercialization strategies for emerging economies.
    • Healthcare System Administrators : Need regional market insights to justify ECMO technology investments, benchmark against peer institutions, and plan critical care infrastructure development aligned with market growth trends.
    • Medical Device Distributors : Seek Rest Of Asia Pacific-specific market intelligence to evaluate distribution partnerships, forecast demand by country, and optimize inventory and supply chain strategies.
    • Healthcare Investment Firms : Require comprehensive regional market analysis to identify investment opportunities in ECMO manufacturers, healthcare providers, and supporting infrastructure companies across Rest Of Asia Pacific.
    • Clinical Research Organizations : Need region-specific ECMO adoption data to design clinical trials, identify patient populations, establish research partnerships, and understand regulatory pathways in Rest Of Asia Pacific markets.

    Key Companies in the Rest Of Asia Pacific ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Regional Market Specificity : Gain detailed insights exclusive to Rest Of Asia Pacific, including country-specific adoption patterns, regulatory environments, and competitive dynamics that differ from broader Asia Pacific trends.
    • Growth Opportunity Identification : Identify high-potential markets within Rest Of Asia Pacific with 6.5% CAGR, enabling strategic market entry and expansion planning for ECMO manufacturers and healthcare providers.
    • Investment Decision Support : Access comprehensive market valuation data (USD 13.1M to USD 18.0M) to support capital allocation decisions, partnership evaluations, and business development strategies in the region.
    • Competitive Intelligence : Understand regional competitive landscape, key players, market consolidation trends, and differentiation opportunities specific to Rest Of Asia Pacific's emerging ECMO market.
    • Strategic Planning Resources : Leverage region-specific forecasts and infrastructure investment trends to develop targeted go-to-market strategies, pricing models, and clinical adoption acceleration programs.

    Frequently asked questions

    What is the current market size of ECMO machines in Middle East & Africa?

    The Middle East & Africa ECMO machines market is valued at USD 13.1 million in 2025 and is projected to reach USD 18.0 million by 2030.

    What is the expected growth rate for ECMO machines in Middle East & Africa?

    Middle East & Africa's ECMO machines market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2030.

    What factors are driving ECMO market growth in Middle East & Africa?

    Middle East & Africa's ECMO market growth is driven by increasing healthcare infrastructure investments, rising prevalence of cardiac and respiratory conditions, and expanding critical care capacity in tertiary care centers.

    How does Middle East & Africa's ECMO market growth compare to global trends?

    Middle East & Africa's 6.5% CAGR exceeds the global ECMO machines market CAGR of 5.8%, indicating stronger regional demand and accelerating adoption.

    Which healthcare settings in Middle East & Africa are adopting ECMO technology?

    Middle East & Africa's tertiary care centers and major hospital facilities are the primary adopters of ECMO systems for managing severe cardiopulmonary failure cases.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status